The Institute for Advanced Medical Research Launches Fibromyalgia Study

By: PRLog
Alpharetta facility offers support for those with fibromyalgia
PRLog - Oct. 21, 2014 - ALPHARETTA, Ga. -- Today the Institute for Advanced Medical Research announced that they will launch a new clinical trial for fibromyalgia on November 1, 2014.  The pivotal phase 3 trial will test the efficacy of a new compound.

Fibromyalgia (FM) can best be described as a chronic pain state caused by excitation of nerves carrying pain signals to the brain.  It is a highly complex disorder with a variety of symptoms that come and go, making it difficult to identify, diagnose and treat.  The disease also includes specific pain trigger points useful in making a clear diagnosis.  Experts predict that approximately 10 million Americans have this disorder, most of them women.

In addition to the chronic, debilitating pain of fibromyalgia, many of the symptoms of fibromyalgia are similar to other medical conditions and actually often co-exists with others including severe fatigue, insomnia, muscle knots, cramping and weakness, brain fog and IBS.

“Currently, there are only three drugs approved for treating fibromyalgia and much needs to be done in the area of research.  There is no cure for fibromyalgia and today treatment is focused on the management of the chronic pain; because of the chronic pain issues, many people with fibromyalgia become withdrawn from family and friends and even become depressed,” offered Angelo Sambunaris, M.D., Founder and President of the Institute.  “This study provides an in-depth diagnostic evaluation and support from an expert at no cost to the participant, providing benefits for both the individual and the advancement of medicine.”

To learn more or schedule an evaluation, please call 770-817-9200, or visit

About the Institute for Advanced Medical Research

The Institute for Advanced Medical Research empowers individuals struggling with neuropsychological conditions to actively participate in their treatment. By educating and informing patients and their families, the team offers them a renewed sense of purpose. Rather than simply being victims of a disease, study participants become health care heroes, creating a personal legacy of advancing medical science.

Adhering to the highest standards of quality and strict ethical principles of medical research, the Institute employs a patient-centered approach that balances a commitment to safety with highly personalized care. Since 1991, the Institute has helped more than 3,000 individuals improve their quality of life while ensuring that millions more can benefit from access to innovative medical treatments. For more information, visit the Institute for Advanced Medical Research website at, or call 770-817-9200.

Read Full Story - The Institute for Advanced Medical Research Launches Fibromyalgia Study | More news from this source

Press release distribution by PRLog

Data & News supplied by
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.